Blockade of TGF-β is ineffective as therapy for systemic sclerosis

  • Published 2007 in Nature Clinical Practice Rheumatology

Abstract

and atherosclerosis, Karvounaris and colleagues investigated the prevalence of the metabolic syndrome in Mediterranean patients with RA. Their case–control study involved 200 consecutive outpatients (aged 63 ± 11 years, 147 women) with RA, and 400 healthy controls from the same population, matched for age and sex. The prevalence of the metabolic syndrome… (More)
DOI: 10.1038/ncprheum0449

Topics

Cite this paper

@article{2007BlockadeOT, title={Blockade of TGF-β is ineffective as therapy for systemic sclerosis}, author={}, journal={Nature Clinical Practice Rheumatology}, year={2007}, volume={3}, pages={196-196} }